Skip to content

Effects of different stages of initial L-T4 treatment intervention on pregnancy outcomes in women with subclinical hypothyroidism

Effects of different stages of initial L-T4 treatment intervention on pregnancy outcomes in women with subclinical hypothyroidism

Status
Recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900022494
Enrollment
Unknown
Registered
2019-04-13
Start date
2019-04-13
Completion date
Unknown
Last updated
2019-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subclinical hypothyroidism

Interventions

begin treatment at pregnancy preparation group:L-T4 therapy
begin treatment at the 0-12 weeks of pregnancy group (including 12 weeks):L-T4 therapy
begin treatment at the 12-24 weeks of pregnancy group (excluding 12 weeks, including 24 weeks):L-T4 therapy
4:no invtervention

Sponsors

the Second Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1)aged 20 to 40 years; 2)all patients were treated with L-T4 for the first time and did not use orther thyroid function interering drugs during pregnancy; 3)the diagnosis of pre-pregnancy subclinical hypothyroidism is in line with China's 2017 guidelines for the diagnosis and treatment of adult hypothyroidism; 4) the diagnosis of pregnancy combined with subclinical hypothyroidism conforms to the guidelines for pregnancy and postpartum thyroid diseases issued by China 2012.

Exclusion criteria

Exclusion criteria: 1)in vitro fertilization;more than two pregnancies;a history of habitual abortion; 2)hyperlipidemia,hypertension and diabetes before pregnancy;having a mental or neurolagical disorder; 3)combined with severe liver,kidney,lung and other organ dysfunction and coagulation abnormalities; 4)have a history of cancer;having acute or chronic infectious diseases or incomplete clinical data;

Design outcomes

Primary

MeasureTime frame
adverse pregnancy outcome;

Countries

China

Contacts

Public ContactYunfeng Shen

the Second Affiliated Hospital of Nanchang University

1041267913@qq.com+86 18970819455

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026